(Q40642287)

22 September 2017

Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia (English)

1 reference

22 September 2017

Sylvia L Anderson

1

1 reference

PubMed ID

12788105

22 September 2017

Jinsong Qiu

series ordinal

2

1 reference

PubMed ID

12788105

22 September 2017

Berish Y Rubin

series ordinal

3

1 reference

22 September 2017

1 June 2003

1 reference

Biochemical and Biophysical Research Communications

22 September 2017

1 reference

22 September 2017

306

1 reference

22 September 2017

1

1 reference

22 September 2017

303-309

1 reference

Familial dysautonomia is caused by mutations of the IKAP gene

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

IKAP is a scaffold protein of the IkappaB kinase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Elongator, a Multisubunit Component of a Novel RNA Polymerase II Holoenzyme for Transcriptional Elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Purification and characterization of the human elongator complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

A novel specific role for I kappa B kinase complex-associated protein in cytosolic stress signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Glycogen Storage Disease Type II: Identification of Four Novel Missense Mutations (D645N, G648S, R672W, R672Q) and Two Insertions/Deletions in the Acid α-Glucosidase Locus of Patients of Differing Phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Cystic fibrosis patients with the 3272-26A?G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Glycogen storage disease type Ib without neutropenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

A second leaky splice-site mutation in the spastin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Purification and characterization of a human tumor necrosis factor from the LuKII cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Antioxidant properties of alpha-tocopherol and alpha-tocotrienol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Hypocholesterolemic activity of synthetic and natural tocotrienols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

Vitamin E activates gene expression via the pregnane X receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900971-9

10.1016/S0006-291X(03)00971-9

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

12788105